# Study Assessing QBS72S For Treating Brain Metastases

> **NCT05305365** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Stanford University** · enrollment: 21 (actual)

## Conditions studied

- Brain Metastases
- Breast Cancer
- Lung Cancer
- Leptomeningeal Disease
- LMD

## Interventions

- **DRUG:** QBS72S

## Key facts

- **NCT ID:** NCT05305365
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-08-16
- **Primary completion:** 2025-06-20
- **Final completion:** 2027-12
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2025-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05305365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05305365, "Study Assessing QBS72S For Treating Brain Metastases". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05305365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*